Detalhe da pesquisa
1.
Blood eosinophils and fractional exhaled nitric oxide are prognostic and predictive biomarkers in childhood asthma.
J Allergy Clin Immunol
; 2024 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38272375
2.
Real-world effectiveness of dupilumab in patients with asthma: Findings from the US ADVANTAGE study.
Ann Allergy Asthma Immunol
; 132(4): 463-468.e1, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37967668
3.
Impact of dupilumab across seasons in patients with type 2, uncontrolled, moderate-to-severe asthma.
Ann Allergy Asthma Immunol
; 132(4): 477-484.e4, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38013139
4.
Targeting Type 2 Inflammation and Epithelial Alarmins in Chronic Obstructive Pulmonary Disease: A Biologics Outlook.
Am J Respir Crit Care Med
; 208(4): 395-405, 2023 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37348121
5.
Real-world effectiveness of dupilumab versus benralizumab and mepolizumab.
Allergy Asthma Proc
; 2024 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38760161
6.
Dupilumab leads to better-controlled asthma and quality of life in children: the VOYAGE study.
Eur Respir J
; 62(5)2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37734856
7.
Efficacy of dupilumab in patients with uncontrolled, moderate-to-severe asthma with fungal sensitization.
Clin Exp Allergy
; 53(10): 1020-1030, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37752621
8.
Dupilumab sustains efficacy in patients with moderate-to-severe type 2 asthma regardless of inhaled corticosteroids dose.
Allergy
; 78(11): 2921-2932, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37431558
9.
Dupilumab reduced impact of severe exacerbations on lung function in patients with moderate-to-severe type 2 asthma.
Allergy
; 78(1): 233-243, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35899469
10.
Dupilumab improves long-term outcomes in patients with uncontrolled, moderate-to-severe GINA-based type 2 asthma, irrespective of allergic status.
Allergy
; 78(8): 2148-2156, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37073882
11.
Assessment of dupilumab in children with moderate-to-severe type 2 asthma with or without evidence of allergic asthma.
Allergy
; 78(8): 2157-2167, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37059696
12.
Long-term efficacy of dupilumab in asthma with or without chronic rhinosinusitis and nasal polyps.
Ann Allergy Asthma Immunol
; 130(2): 215-224, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36356712
13.
The long-term effect of dupilumab on dyspnea, sleep, and activity in oral corticosteroid-dependent severe asthma.
Ann Allergy Asthma Immunol
; 130(3): 298-304, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36509407
14.
Efficacy of dupilumab in patients with moderate-to-severe asthma and persistent airflow obstruction.
Ann Allergy Asthma Immunol
; 130(2): 206-214.e2, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36332763
15.
Dupilumab pharmacokinetics and effect on type 2 biomarkers in children with moderate-to-severe asthma.
Ann Allergy Asthma Immunol
; 131(1): 44-51.e4, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36958470
16.
Dupilumab long-term efficacy in patients with non-OCS-dependent asthma with and without evidence of allergic asthma.
J Asthma
; 60(9): 1767-1774, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36876957
17.
Dupilumab efficacy and safety in Latin American patients with uncontrolled, moderate-to-severe asthma: phase 3 LIBERTY ASTHMA QUEST study.
J Asthma
; 60(5): 981-990, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36066123
18.
Dupilumab efficacy in patients with chronic rhinosinusitis with nasal polyps with and without allergic rhinitis.
Allergy Asthma Proc
; 44(4): 265-274, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37480206
19.
Efficacy of dupilumab in patients with uncontrolled, moderate-to-severe asthma recruited from Japanese centers in the phase 3 LIBERTY ASTHMA TRAVERSE study.
Allergol Int
; 72(1): 89-99, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36114102
20.
Disease Burden and Unmet Need in Eosinophilic Esophagitis.
Am J Gastroenterol
; 117(8): 1231-1241, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35417421